Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Bose, Prithviraj, Vachhani, Pankit, Cortes, Jorge E.
Published in Current Treatment Options in Oncology (01.03.2017)
Published in Current Treatment Options in Oncology (01.03.2017)
Get full text
Journal Article
Book Review
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
Cortes, Jorge E, Saglio, Giuseppe, Kantarjian, Hagop M, Baccarani, Michele, Mayer, Jiří, Boqué, Concepción, Shah, Neil P, Chuah, Charles, Casanova, Luis, Bradley-Garelik, Brigid, Manos, George, Hochhaus, Andreas
Published in Journal of clinical oncology (10.07.2016)
Published in Journal of clinical oncology (10.07.2016)
Get full text
Journal Article
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
Cortes, Jorge E, Gambacorti-Passerini, Carlo, Deininger, Michael W, Mauro, Michael J, Chuah, Charles, Kim, Dong-Wook, Dyagil, Irina, Glushko, Nataliia, Milojkovic, Dragana, le Coutre, Philipp, Garcia-Gutierrez, Valentin, Reilly, Laurence, Jeynes-Ellis, Allison, Leip, Eric, Bardy-Bouxin, Nathalie, Hochhaus, Andreas, Brümmendorf, Tim H
Published in Journal of clinical oncology (20.01.2018)
Published in Journal of clinical oncology (20.01.2018)
Get full text
Journal Article
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs
Réa, Delphine, Mauro, Michael J., Boquimpani, Carla, Minami, Yosuke, Lomaia, Elza, Voloshin, Sergey, Turkina, Anna, Kim, Dong-Wook, Apperley, Jane F., Abdo, Andre, Fogliatto, Laura Maria, Kim, Dennis Dong Hwan, le Coutre, Philipp, Saussele, Susanne, Annunziata, Mario, Hughes, Timothy P., Chaudhri, Naeem, Sasaki, Koji, Chee, Lynette, García-Gutiérrez, Valentin, Cortes, Jorge E., Aimone, Paola, Allepuz, Alex, Quenet, Sara, Bédoucha, Véronique, Hochhaus, Andreas
Published in Blood (25.11.2021)
Published in Blood (25.11.2021)
Get full text
Journal Article
Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial
Cortes, Jorge E., Kim, Dong-Wook, Pinilla-Ibarz, Javier, le Coutre, Philipp D., Paquette, Ronald, Chuah, Charles, Nicolini, Franck E., Apperley, Jane F., Khoury, H. Jean, Talpaz, Moshe, DeAngelo, Daniel J., Abruzzese, Elisabetta, Rea, Delphine, Baccarani, Michele, Müller, Martin C., Gambacorti-Passerini, Carlo, Lustgarten, Stephanie, Rivera, Victor M., Haluska, Frank G., Guilhot, François, Deininger, Michael W., Hochhaus, Andreas, Hughes, Timothy P., Shah, Neil P., Kantarjian, Hagop M.
Published in Blood (26.07.2018)
Published in Blood (26.07.2018)
Get full text
Journal Article
Omacetaxine: A Protein Translation Inhibitor for Treatment of Chronic Myelogenous Leukemia
GANDHI, Varsha, PLUNKETT, William, CORTES, Jorge E
Published in Clinical cancer research (01.04.2014)
Published in Clinical cancer research (01.04.2014)
Get full text
Journal Article
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Daver, Naval, Garcia-Manero, Guillermo, Basu, Sreyashi, Boddu, Prajwal C, Alfayez, Mansour, Cortes, Jorge E, Konopleva, Marina, Ravandi-Kashani, Farhad, Jabbour, Elias, Kadia, Tapan, Nogueras-Gonzalez, Graciela M, Ning, Jing, Pemmaraju, Naveen, DiNardo, Courtney D, Andreeff, Michael, Pierce, Sherry A, Gordon, Tauna, Kornblau, Steven M, Flores, Wilmer, Alhamal, Zainab, Bueso-Ramos, Carlos, Jorgensen, Jeffrey L, Patel, Keyur P, Blando, Jorge, Allison, James P, Sharma, Padmanee, Kantarjian, Hagop
Published in Cancer discovery (01.03.2019)
Published in Cancer discovery (01.03.2019)
Get full text
Journal Article
Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Status
CORTES, Jorge E, KANTARJIAN, Hagop, LEVIS, Mark, FORAN, James M, GHIRDALADZE, Darejan, ZODELAVA, Mamia, BORTHAKUR, Gautam, GAMMON, Guy, TRONE, Denise, ARMSTRONG, Robert C, JAMES, Joyce
Published in Journal of clinical oncology (10.10.2013)
Published in Journal of clinical oncology (10.10.2013)
Get full text
Journal Article
Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015
Thompson, Philip A., MBBS, Kantarjian, Hagop M., MD, Cortes, Jorge E., MD
Published in Mayo Clinic proceedings (01.10.2015)
Published in Mayo Clinic proceedings (01.10.2015)
Get full text
Journal Article
Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial
CORTES, Jorge E, KIM, Dong-Wook, GAMBACORTI-PASSERINI, Carlo, KANTARJIAN, Hagop M, BRÜMMENDORF, Tim H, DYAGIL, Irina, GRISKEVICIUS, Laimonas, MALHOTRA, Hemant, POWELL, Christine, GOGAT, Karin, COUNTOURIOTIS, Athena M
Published in Journal of clinical oncology (01.10.2012)
Published in Journal of clinical oncology (01.10.2012)
Get full text
Journal Article
Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD–mutated, relapsed or refractory AML
Cortes, Jorge E., Tallman, Martin S., Schiller, Gary J., Trone, Denise, Gammon, Guy, Goldberg, Stuart L., Perl, Alexander E., Marie, Jean-Pierre, Martinelli, Giovanni, Kantarjian, Hagop M., Levis, Mark J.
Published in Blood (09.08.2018)
Published in Blood (09.08.2018)
Get full text
Journal Article
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
Brümmendorf, Tim H., Cortes, Jorge E., Milojkovic, Dragana, Gambacorti-Passerini, Carlo, Clark, Richard E., le Coutre, Philipp, Garcia-Gutierrez, Valentin, Chuah, Charles, Kota, Vamsi, Lipton, Jeffrey H., Rousselot, Philippe, Mauro, Michael J., Hochhaus, Andreas, Hurtado Monroy, Rafael, Leip, Eric, Purcell, Simon, Yver, Anne, Viqueira, Andrea, Deininger, Michael W.
Published in Leukemia (01.07.2022)
Published in Leukemia (01.07.2022)
Get full text
Journal Article
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia
Morita, Kiyomi, Kantarjian, Hagop M, Wang, Feng, Yan, Yuanqing, Bueso-Ramos, Carlos, Sasaki, Koji, Issa, Ghayas C, Wang, Sa, Jorgensen, Jeffrey, Song, Xingzhi, Zhang, Jianhua, Tippen, Samantha, Thornton, Rebecca, Coyle, Marcus, Little, Latasha, Gumbs, Curtis, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney D, Konopleva, Marina, Andreeff, Michael, Ravandi, Farhad, Cortes, Jorge E, Kadia, Tapan, Jabbour, Elias, Garcia-Manero, Guillermo, Patel, Keyur P, Futreal, P Andrew, Takahashi, Koichi
Published in Journal of clinical oncology (20.06.2018)
Published in Journal of clinical oncology (20.06.2018)
Get full text
Journal Article
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
Wang, Wei, Cortes, Jorge E., Tang, Guilin, Khoury, Joseph D., Wang, Sa, Bueso-Ramos, Carlos E., DiGiuseppe, Joseph A., Chen, Zi, Kantarjian, Hagop M., Medeiros, L.Jeffrey, Hu, Shimin
Published in Blood (02.06.2016)
Published in Blood (02.06.2016)
Get full text
Journal Article
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
Cortes, Jorge E, Kantarjian, Hagop, Shah, Neil P, Bixby, Dale, Mauro, Michael J, Flinn, Ian, O'Hare, Thomas, Hu, Simin, Narasimhan, Narayana I, Rivera, Victor M, Clackson, Tim, Turner, Christopher D, Haluska, Frank G, Druker, Brian J, Deininger, Michael W.N, Talpaz, Moshe
Published in The New England journal of medicine (29.11.2012)
Published in The New England journal of medicine (29.11.2012)
Get full text
Journal Article
Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment
WALTER, Roland B, OTHUS, Megan, BORTHAKUR, Gautam, RAVANDI, Farhad, CORTES, Jorge E, PIERCE, Sherry A, APPELBAUM, Frederick R, KANTARJIAN, Hagop A, ESTEY, Elihu H
Published in Journal of clinical oncology (20.11.2011)
Published in Journal of clinical oncology (20.11.2011)
Get full text
Journal Article
Update on the role of gemtuzumab-ozogamicin in the treatment of acute myeloid leukemia
Get full text
Book Review
Journal Article
Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034
Shah, Neil P., Rousselot, Philippe, Schiffer, Charles, Rea, Delphine, Cortes, Jorge E., Milone, Jorge, Mohamed, Hesham, Healey, Diane, Kantarjian, Hagop, Hochhaus, Andreas, Saglio, Giuseppe
Published in American journal of hematology (01.09.2016)
Published in American journal of hematology (01.09.2016)
Get full text
Journal Article
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Khoury, H. Jean, Cortes, Jorge E., Kantarjian, Hagop M., Gambacorti-Passerini, Carlo, Baccarani, Michele, Kim, Dong-Wook, Zaritskey, Andrey, Countouriotis, Athena, Besson, Nadine, Leip, Eric, Kelly, Virginia, Brümmendorf, Tim H.
Published in Blood (12.04.2012)
Published in Blood (12.04.2012)
Get full text
Journal Article